It’s been a tough session for the AIM All Share on Wednesday with the index trading almost seven points down at 4pm, posting lows not seen in more than a month as a result.
- Verditek +75%
- CAP-XX +31%
- Ensilica +14%
- Destiny Pharma -16%
- Anexo -15%
Verditek LON:VDTK topped the board, adding 75% by 4pm following news this morning that the company had entered into a conditional sale and purchase agreement to dispose of its solar business. This would clear liabilities to bondholders and is accompanied by both fresh funding and a boardroom reshuffle, but the uptick makes little impact on the notable losses incurred by the company over the last few years.
CAP-XX LON:CPX is back on the list, this time as one of the biggest gainers by copy time. Following yesterday’s shake down, management issued a note this morning confirming that whilst the abandoned patent lawsuit in the US could still see some additional costs incurred, these are likely to be limited.
Ensilica LON:ENSI gets the notable mention, up 14% as we head into the close. The company notified the market of a $20m contract win for a major US electronics manufacturer, with the orders to be delivered in calendar years 2025 and 2026. Management add that they are actively pursuing other similar orders in the US.
- Small Cap Stocks: Capital Metals, Seascape Energy, Oracle Power
- Three Quick Facts: Boohoo, DS Smith and CAP-XX
- Small Cap Stocks: Microsalt, Proton Motor Power, Eckoh
Destiny Pharma LON:DEST was the day’s laggard but losses were limited to just 16%. A clinical update issued at the end of last month knocked sentiment and no comms from management since then is doing little to engender support. Trade was however lumpy and heading into the close the stock sat on a 6% spread.
Anexo LON:ANX was also struggling, down 15% heading towards the bell. There’s no news and the number of trades looks limited but volumes are elevated. As a result the gains delivered off the back of the court ruling just under two weeks ago have now been fully eroded.